Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment
暂无分享,去创建一个
[1] L. Becker,et al. Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak–Stat5 Pathway , 2007, Circulation research.
[2] D. Busch,et al. Chemokine Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood: A Critical Role for P-Selectin Expressed on Activated Platelets , 2007, Circulation.
[3] S. Bevan,et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.
[4] S. McQuaid,et al. Upregulation of ADAM-17 expression in active lesions in multiple sclerosis , 2006, Multiple sclerosis.
[5] S. K. Park,et al. Resveratrol Suppresses Tumor Necrosis Factor-α-Induced Fractalkine Expression in Endothelial Cells , 2006, Molecular Pharmacology.
[6] Steffen Jung,et al. The FASEB Journal • Research Communication The neuronal chemokine CX3CL1/fractalkine , 2022 .
[7] N. Miyasaka,et al. Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice1 , 2005, The Journal of Immunology.
[8] J. Greenwood,et al. Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] H. Lassmann,et al. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin , 2005, Journal of Neuroinflammation.
[10] M. Woodroofe,et al. ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.
[11] R. Black,et al. Tumour necrosis factor‐α stimulates expression of TNF‐α converting enzyme in endothelial cells , 2004 .
[12] U. Walter,et al. Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. , 2004, Blood.
[13] G. Davies-Jones,et al. Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells , 2003, Journal of Neuroimmunology.
[14] R. Ravid,et al. CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis , 2003, Journal of neuropathology and experimental neurology.
[15] F. Fahrenholz,et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.
[16] F. Luscinskas,et al. Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes , 2003, The Journal of experimental medicine.
[17] H. Hartung,et al. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system , 2003, Journal of Neuroimmunology.
[18] D. Huszar,et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury , 2002, Journal of Neuroimmunology.
[19] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[20] I. Charo,et al. Tumor Necrosis Factor- (cid:1) -converting Enzyme Mediates the Inducible Cleavage of Fractalkine* , 2022 .
[21] C. Blobel,et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.
[22] M. Woodroofe,et al. Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS , 2001, Glia.
[23] P. Slocombe,et al. The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 , 2000, FEBS letters.
[24] R. Ye,et al. NF‐κB‐dependent fractalkine induction in rat aortic endothelial cells stimulated by IL‐1β, TNF‐α, and LPS , 2000 .
[25] R. Black,et al. Adamalysins: A Family of Metzincins Including TNF‐α Converting Enzyme (TACE) , 1999 .
[26] P. Slocombe,et al. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .
[27] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[28] R. Huber,et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.
[29] J. Gutiérrez-Ramos,et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation , 1997, Nature.
[30] M. Lambert,et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.
[31] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[32] Wei Wang,et al. A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.
[33] W. Brück,et al. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells , 1995, Journal of Neuroimmunology.